annual EBIT:
-$143.09M-$88.97M(-164.38%)Summary
- As of today (September 14, 2025), MLTX annual earnings before interest & taxes is -$143.09 million, with the most recent change of -$88.97 million (-164.38%) on December 31, 2024.
- During the last 3 years, MLTX annual EBIT has fallen by -$89.51 million (-167.08%).
- MLTX annual EBIT is now -135146.79% below its all-time high of -$105.80 thousand, reached on December 1, 2020.
Performance
MLTX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$60.70M-$13.21M(-27.83%)Summary
- As of today (September 14, 2025), MLTX quarterly earnings before interest & taxes is -$60.70 million, with the most recent change of -$13.21 million (-27.83%) on June 30, 2025.
- Over the past year, MLTX quarterly EBIT has dropped by -$30.12 million (-98.50%).
Performance
MLTX quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$200.88M-$30.12M(-17.64%)Summary
- As of today (September 14, 2025), MLTX TTM earnings before interest & taxes is -$200.88 million, with the most recent change of -$30.12 million (-17.64%) on June 30, 2025.
- Over the past year, MLTX TTM EBIT has dropped by -$122.47 million (-156.20%).
Performance
MLTX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
MLTX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -164.4% | -98.5% | -156.2% |
| 3 y3 years | -167.1% | -243.9% | -271.0% |
| 5 y5 years | -10000.0% | -100.0% | -100.0% |
MLTX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -167.1% | at low | -369.4% | at low | -271.1% | at low |
| 5 y | 5-year | <-9999.0% | at low | <-9999.0% | at low | <-9999.0% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low | <-9999.0% | at low |
MLTX EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$60.70M(+27.8%) | -$200.88M(+17.6%) |
| Mar 2025 | - | -$47.48M(-4.2%) | -$170.76M(+19.3%) |
| Dec 2024 | -$143.09M(+164.4%) | -$49.58M(+15.0%) | -$143.09M(+31.8%) |
| Sep 2024 | - | -$43.11M(+41.0%) | -$108.54M(+38.4%) |
| Jun 2024 | - | -$30.58M(+54.3%) | -$78.40M(+28.5%) |
| Mar 2024 | - | -$19.82M(+31.9%) | -$61.01M(+12.7%) |
| Dec 2023 | -$54.12M(-16.8%) | -$15.03M(+15.8%) | -$54.12M(-3.0%) |
| Sep 2023 | - | -$12.98M(-1.6%) | -$55.79M(-3.1%) |
| Jun 2023 | - | -$13.19M(+2.0%) | -$57.58M(-7.2%) |
| Mar 2023 | - | -$12.93M(-22.5%) | -$62.05M(-4.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | -$65.06M(+21.4%) | -$16.70M(+13.0%) | -$65.06M(+3.9%) |
| Sep 2022 | - | -$14.77M(-16.3%) | -$62.64M(+15.7%) |
| Jun 2022 | - | -$17.65M(+10.7%) | -$54.14M(-21.7%) |
| Mar 2022 | - | -$15.94M(+11.7%) | -$69.17M(+29.7%) |
| Dec 2021 | -$53.58M(>+9900.0%) | -$14.28M(+127.8%) | -$53.32M(+36.2%) |
| Sep 2021 | - | -$6.27M(-80.8%) | -$39.14M(+19.1%) |
| Jun 2021 | - | -$32.68M(>+9900.0%) | -$32.88M(>+9900.0%) |
| Mar 2021 | - | -$94.10K(-6.6%) | -$194.90K(+93.4%) |
| Dec 2020 | -$105.80K | -$100.80K(<-9900.0%) | -$100.80K(<-9900.0%) |
| Sep 2020 | - | $0.00 | $0.00 |
FAQ
- What is MoonLake Immunotherapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual EBIT year-on-year change?
- What is MoonLake Immunotherapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly EBIT year-on-year change?
- What is MoonLake Immunotherapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics TTM EBIT year-on-year change?
What is MoonLake Immunotherapeutics annual earnings before interest & taxes?
The current annual EBIT of MLTX is -$143.09M
What is the all time high annual EBIT for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual earnings before interest & taxes is -$105.80K
What is MoonLake Immunotherapeutics annual EBIT year-on-year change?
Over the past year, MLTX annual earnings before interest & taxes has changed by -$88.97M (-164.38%)
What is MoonLake Immunotherapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of MLTX is -$60.70M
What is the all time high quarterly EBIT for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly earnings before interest & taxes is $0.00
What is MoonLake Immunotherapeutics quarterly EBIT year-on-year change?
Over the past year, MLTX quarterly earnings before interest & taxes has changed by -$30.12M (-98.50%)
What is MoonLake Immunotherapeutics TTM earnings before interest & taxes?
The current TTM EBIT of MLTX is -$200.88M
What is the all time high TTM EBIT for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high TTM earnings before interest & taxes is $0.00
What is MoonLake Immunotherapeutics TTM EBIT year-on-year change?
Over the past year, MLTX TTM earnings before interest & taxes has changed by -$122.47M (-156.20%)